Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study

ClinicalTrials.gov ID: NCT04810962

Public ClinicalTrials.gov record NCT04810962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery, Including a Corneal Endothelial Cell Sub-study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a randomized, parallel-group, double-masked fashion. The subjects will have undergone routine cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day; POD1) after uncomplicated surgery for eligibility for randomization to study treatment. The study comprises the Main Study and the Endothelial Cell Sub-study.

Study identification

NCT ID
NCT04810962
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Formosa Pharmaceuticals, Inc.
Industry
Enrollment
370 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2021 (Actual)
Primary completion
Jul 6, 2022 (Actual)
Completion
Jul 6, 2022 (Actual)
Last update posted
Jul 25, 2023

2021 – 2022

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Arizona Eye Center Chandler Arizona 85224 —
Carrot Eye Center Mesa Arizona 85260 —
Cornea and Cataract Consultants of Arizona Phoenix Arizona 85032 —
Orange County Ophthalmology Medical Group Garden Grove California 92843 —
Premiere Practice Management, LLC Los Angeles California 90013 —
LoBue Laser and Eye Medical Center Inc Murrieta California 92562 —
Visionary Research Institute Newport Beach California 92663 —
North Bay Eye Associates Petaluma California 94954 —
Wolstan and Goldberg Eye Associates Torrance California 90505 —
Michael K. Tran, MD, Inc. Westminster California 92683 —
Rand Eye Institute Deerfield Beach Florida 33064 —
Eye Associates for Fort Myers Fort Myers Florida 33901 —
Levenson Eye Associates Jacksonville Florida 32204 —
International Research Center Tampa Florida 33603 —
Dixon Eye Care Albany Georgia 31701 —
Clayton Eye Clinical Research LLC Morrow Georgia 30260 —
Chicago Cornea Consultants Hoffman Estates Illinois 60169 —
Stiles Eyecare Excellence and Glaucoma Institute, PA Overland Park Kansas 66213 —
The Eye Care Center Louisville Kentucky 40206 —
Fraser Eye Center Fraser Michigan 48026 —
Ophthalmology Associates St Louis Missouri 63131 —
Wellish Vision Institute Las Vegas Nevada 89119 —
Metropolitan Eye Research and Surgery Institute Palisades Park New Jersey 07650 —
Alterman, Modi and Wolter Poughkeepsie New York 12603 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Eye Care Specialists Kingston Pennsylvania 18704 —
Carolina Cataract and Laser Center Ladson South Carolina 29456 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Houston Eye Associates Houston Texas 70025 —
DCT-Shah Research Institute LLC dba Discovery Clinical Trials Mission Texas 78572 —
Round Rock Eye Consultants Round Rock Texas 78681 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04810962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04810962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →